MR VOLUMETRY FOR MONITORING INTRAMUSCULAR BROMOCRIPTINE TREATMENT IN MACROPROLACTINOMAS

Citation
H. Benesch et al., MR VOLUMETRY FOR MONITORING INTRAMUSCULAR BROMOCRIPTINE TREATMENT IN MACROPROLACTINOMAS, Journal of computer assisted tomography, 19(6), 1995, pp. 866-870
Citations number
14
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
03638715
Volume
19
Issue
6
Year of publication
1995
Pages
866 - 870
Database
ISI
SICI code
0363-8715(1995)19:6<866:MVFMIB>2.0.ZU;2-N
Abstract
Objective: To assess volumetric changes of pituitary prolactinomas, we applied a threshold-based segmentation algorithm in two patients duri ng intramuscular bromocriptine treatment. Materials and Methods: Tumor volumes were calculated from contiguous slices of a 3D GE sequence an d from conventional SE images. Results: After a single 50 mg i.m. brom ocriptine administration, the prolactinoma volumes decreased by 25 and 35% within 7 and 11 days, respectively. Volume calculations from 3D G E images were more accurate than calculations from 3 mm 2D SE images, especially for smaller tumors. A decrease of prolactinoma size was par alleled by a decrease of serum prolactin levels and correlated with an improvement of visual field and endocrine function in both patients. The end of the bromocriptine effect was indicated by a reincreasing tu mor volume, which was observed after 30 days in the first patient and after 43 days in the second patient. Conclusion: Our results suggest t hat MR volumetry represents a useful tool to monitor changes of prolac tinoma volume during bromocriptine treatment and may improve the clini cal management of these patients.